{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:18:13Z","timestamp":1780417093768,"version":"3.54.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,6,16]],"date-time":"2009-06-16T00:00:00Z","timestamp":1245110400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00213-009-1591-7","type":"journal-article","created":{"date-parts":[[2009,6,15]],"date-time":"2009-06-15T06:00:07Z","timestamp":1245045607000},"page":"551-561","source":"Crossref","is-referenced-by-count":40,"title":["The endocannabinoid system as a target for modelling psychosis"],"prefix":"10.1007","volume":"206","author":[{"given":"Dagmar","family":"Koethe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Markus","family":"Leweke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,16]]},"reference":[{"key":"1591_CR1","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1192\/bjp.104.437.972","volume":"104","author":"F Ames","year":"1958","unstructured":"Ames F (1958) A clinical and metabolic study of acute intoxication with cannabis sative and its role in the model psychoses. J Ment Sci 104:972\u2013999","journal-title":"J Ment Sci"},{"key":"1591_CR2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.184.2.110","volume":"184","author":"L Arseneault","year":"2004","unstructured":"Arseneault L, Cannon M, Witton J, Murray RM (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184:110\u2013117","journal-title":"Br J Psychiatry"},{"key":"1591_CR3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/bjp.178.2.101","volume":"178","author":"C Ashton","year":"2001","unstructured":"Ashton C (2001) Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 178:101\u2013106","journal-title":"Br J Psychiatry"},{"key":"1591_CR4","first-page":"337","volume":"5","author":"K Beringer","year":"1932","unstructured":"Beringer K, von Baeyer W, Marx H (1932) Zur Klinik des Haschischrausches. Nervenarzt 5:337\u2013350","journal-title":"Nervenarzt"},{"key":"1591_CR5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","volume":"134","author":"T Bisogno","year":"2001","unstructured":"Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134:845\u2013852","journal-title":"Br J Pharmacol"},{"key":"1591_CR6","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","volume":"64","author":"SJ Borgwardt","year":"2008","unstructured":"Borgwardt SJ, Allen P, Bhattacharyya S, Fusar-Poli P, Crippa JA, Seal ML, Fraccaro V, Atakan Z, Martin-Santos R, O'Carroll C, Rubia K, McGuire PK (2008) Neural basis of delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry 64:966\u2013673","journal-title":"Biol Psychiatry"},{"key":"1591_CR7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/npp.2008.138","volume":"34","author":"MG Bossong","year":"2009","unstructured":"Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, van Gerven JM, Ramsey NF, Lammertsma AA, Kahn RS (2009) Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 34:759\u2013766","journal-title":"Neuropsychopharmacology"},{"key":"1591_CR8","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1073\/pnas.0703472104","volume":"104","author":"HD Burns","year":"2007","unstructured":"Burns HD, Van Laere K, Sanabria-Bohorquez S, Hamill TG, Bormans G, Eng WS, Gibson R, Ryan C, Connolly B, Patel S, Krause S, Vanko A, Van Hecken A, Dupont P, De Lepeleire I, Rothenberg P, Stoch SA, Cote J, Hagmann WK, Jewell JP, Lin LS, Liu P, Goulet MT, Gottesdiener K, Wagner JA, de Hoon J, Mortelmans L, Fong TM, Hargreaves RJ (2007) [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A 104:9800\u20139805","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1591_CR9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02245075","volume":"115","author":"LD Chait","year":"1994","unstructured":"Chait LD, Perry JL (1994) Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology (Berl) 115:340\u2013349","journal-title":"Psychopharmacology (Berl)"},{"key":"1591_CR10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1073858406296601","volume":"13","author":"L Chang","year":"2007","unstructured":"Chang L, Chronicle EP (2007) Functional imaging studies in cannabis users. Neuroscientist 13:422\u2013432","journal-title":"Neuroscientist"},{"issue":"Suppl 1","key":"1591_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuropharm.2008.07.018","volume":"56","author":"JR Clapper","year":"2009","unstructured":"Clapper JR, Mangieri RA, Piomelli D (2009) The endocannabinoid system as a target for the treatment of cannabis dependence. Neuropharmacology 56(Suppl 1):235\u2013243","journal-title":"Neuropharmacology"},{"key":"1591_CR12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","volume":"29","author":"JA Crippa","year":"2004","unstructured":"Crippa JA, Zuardi AW, Garrido GE, Wichert-Ana L, Guarnieri R, Ferrari L, Azevedo-Marques PM, Hallak JE, McGuire PK, Filho Busatto G (2004) Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology 29:417\u2013426","journal-title":"Neuropsychopharmacology"},{"key":"1591_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-002-1169-0","volume":"164","author":"HV Curran","year":"2002","unstructured":"Curran HV, Brignell C, Fletcher S, Middleton P, Henry J (2002) Cognitive and subjective dose-response effects of acute oral delta(9)-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl) 164:61\u201370","journal-title":"Psychopharmacology (Berl)"},{"key":"1591_CR14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cpt1976193300","volume":"19","author":"WS Dalton","year":"1976","unstructured":"Dalton WS, Martz R, Lemberger L, Rodda BE, Forney RB (1976) Influence of cannabidiol on delta-9-tetrahydrocannabinol effects. Clin Pharmacol Ther 19:300\u2013309","journal-title":"Clin Pharmacol Ther"},{"key":"1591_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","volume":"103","author":"B Dean","year":"2001","unstructured":"Dean B, Sundram S, Bradbury R, Scarr E, Copolov D (2001) Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 103:9\u201315","journal-title":"Neuroscience"},{"key":"1591_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","volume":"34","author":"WA Devane","year":"1988","unstructured":"Devane WA, Dysarz FA III, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605\u2013613","journal-title":"Mol Pharmacol"},{"key":"1591_CR17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrd2553","volume":"7","author":"V Marzo Di","year":"2008","unstructured":"Di Marzo V (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7:438\u2013455","journal-title":"Nat Rev Drug Discov"},{"key":"1591_CR18","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","volume":"29","author":"CD D'Souza","year":"2004","unstructured":"D'Souza CD, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu Y-T, Braley G, Gueorguieva R, Krystal JH (2004) The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29:1558\u20131572","journal-title":"Neuropsychopharmacology"},{"key":"1591_CR19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","volume":"57","author":"DC D'Souza","year":"2005","unstructured":"D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH (2005) Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 57:594\u2013608","journal-title":"Biol Psychiatry"},{"key":"1591_CR20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-007-1042-2","volume":"198","author":"DC D'Souza","year":"2008","unstructured":"D'Souza DC, Braley G, Blaise R, Vendetti M, Oliver S, Pittman B, Ranganathan M, Bhakta S, Zimolo Z, Cooper T, Perry E (2008a) Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of delta-9-tetrahydrocannabinol in humans. Psychopharmacology (Berl) 198:587\u2013603","journal-title":"Psychopharmacology (Berl)"},{"key":"1591_CR21","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","volume":"33","author":"DC D'Souza","year":"2008","unstructured":"D'Souza DC, Ranganathan M, Braley G, Gueorguieva R, Zimolo Z, Cooper T, Perry E, Krystal J (2008b) Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology 33:2505\u20132516","journal-title":"Neuropsychopharmacology"},{"key":"1591_CR22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","volume":"65","author":"SM Eggan","year":"2008","unstructured":"Eggan SM, Hashimoto T, Lewis DA (2008) Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry 65:772\u2013784","journal-title":"Arch Gen Psychiatry"},{"key":"1591_CR23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","volume":"78","author":"MA Elsohly","year":"2005","unstructured":"Elsohly MA, Slade D (2005) Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci 78:539\u2013548","journal-title":"Life Sci"},{"key":"1591_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","volume":"66","author":"P Fusar-Poli","year":"2009","unstructured":"Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R, Seal M, Surguladze SA, O\u2019Carrol C, Atakan Z, Zuardi AW, McGuire PK (2009) Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 66:95\u2013105","journal-title":"Arch Gen Psychiatry"},{"key":"1591_CR25","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Y Gaoni","year":"1964","unstructured":"Gaoni Y, Mechoulam R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:1646\u20131647","journal-title":"J Am Chem Soc"},{"key":"1591_CR26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/7268","volume":"2","author":"A Giuffrida","year":"1999","unstructured":"Giuffrida A, Parsons LH, Kerr TM, de Fonseca FR, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358\u2013363","journal-title":"Nat Neurosci"},{"key":"1591_CR27","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","volume":"29","author":"A Giuffrida","year":"2004","unstructured":"Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, Klosterkotter J, Piomelli D (2004) Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 29:2108\u20132114","journal-title":"Neuropsychopharmacology"},{"key":"1591_CR28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","volume":"77","author":"M Glass","year":"1997","unstructured":"Glass M, Dragunow M, Faull RL (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77:299\u2013318","journal-title":"Neuroscience"},{"issue":"Suppl 4","key":"1591_CR29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00014180","volume":"249","author":"H H\u00e4fner","year":"1999","unstructured":"H\u00e4fner H, an der Heiden W (1999) The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies. Eur Arch Psychiatry Clin Neurosci 249(Suppl 4):14\u201326","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1591_CR30","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932\u20131936","journal-title":"Proc Natl Acad Sci USA"},{"key":"1591_CR31","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/BF01946311","volume":"29","author":"LE Hollister","year":"1973","unstructured":"Hollister LE (1973) Cannabidiol and cannabinol in man. Experientia 29:825\u2013826","journal-title":"Experientia"},{"key":"1591_CR32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/cpt197518180","volume":"18","author":"LE Hollister","year":"1975","unstructured":"Hollister LE, Gillespie H (1975) Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol. Clin Pharmacol Ther 18:80\u201383","journal-title":"Clin Pharmacol Ther"},{"key":"1591_CR33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF00401256","volume":"11","author":"H Isbell","year":"1967","unstructured":"Isbell H, Gorodetzsky CW, Jasinski D, Claussen U, von Spulak F, Korte F (1967) Effects of (\u2212)delta-9-trans-tetrahydrocannabinol in man. Psychopharmacologia 11:184\u2013188","journal-title":"Psychopharmacologia"},{"key":"1591_CR34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.178.2.116","volume":"178","author":"A Johns","year":"2001","unstructured":"Johns A (2001) Psychiatric effects of cannabis. Br J Psychiatry 178:116\u2013122","journal-title":"Br J Psychiatry"},{"key":"1591_CR35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","volume":"89","author":"M Kano","year":"2009","unstructured":"Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89:309\u2013380","journal-title":"Physiol Rev"},{"key":"1591_CR36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","volume":"28","author":"IG Karniol","year":"1974","unstructured":"Karniol IG, Shirakawa I, Kasinski N, Pfeferman A, Carlini EA (1974a) Cannabidiol interferes with the effects of \u03949-tetrahydrocannabinol in man. Eur J Pharmacol 28:172\u2013177","journal-title":"Eur J Pharmacol"},{"key":"1591_CR37","first-page":"230","volume":"212","author":"IG Karniol","year":"1974","unstructured":"Karniol IG, Takahashi RN, Musty RE (1974b) Effects of delta9-tetrahydrocannabinol and cannabinol on operant performance in rats. Arch Int Pharmacodyn Ther 212:230\u2013237","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"1591_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(98)00264-0","volume":"63","author":"JM Kirk","year":"1999","unstructured":"Kirk JM, de Wit H (1999) Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacol Biochem Behav 63:137\u2013142","journal-title":"Pharmacol Biochem Behav"},{"key":"1591_CR39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0091-3057(97)00414-0","volume":"59","author":"JM Kirk","year":"1998","unstructured":"Kirk JM, Doty P, De Wit H (1998) Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol. Pharmacol Biochem Behav 59:287\u2013293","journal-title":"Pharmacol Biochem Behav"},{"key":"1591_CR40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.schres.2006.07.023","volume":"88","author":"D Koethe","year":"2006","unstructured":"Koethe D, Gerth CW, Neatby MA, Haensel A, Thies M, Schneider U, Emrich HM, Klosterkotter J, Schultze-Lutter F, Leweke FM (2006) Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness. Schizophr Res 88:142\u2013150","journal-title":"Schizophr Res"},{"key":"1591_CR41","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00702-007-0660-5","volume":"114","author":"D Koethe","year":"2007","unstructured":"Koethe D, Llenos IC, Dulay JR, Hoyer C, Torrey EF, Leweke FM, Weis S (2007) Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. J Neural Transm 114:1055\u20131063","journal-title":"J Neural Transm"},{"key":"1591_CR42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1192\/bjp.bp.108.053843","volume":"194","author":"D Koethe","year":"2009","unstructured":"Koethe D, Giuffrida A, Schreiber D, Hellmich M, Schultze-Lutter F, Ruhrmann S, Klosterkotter J, Piomelli D, Leweke FM (2009a) Anandamide elevation in CSF of prodromal states of schizophrenia. Br J Psychiatry 194:371\u2013372","journal-title":"Br J Psychiatry"},{"key":"1591_CR43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00406-008-0851-6","volume":"259","author":"D Koethe","year":"2009","unstructured":"Koethe D, Kranaster L, Hoyer C, Gross S, Neatby MA, Schultze-Lutter F, Ruhrmann S, Klosterkotter J, Hellmich M, Leweke FM (2009b) Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naive and treated schizophrenia. Eur Arch Psychiatry Clin Neurosci 259:195\u2013202","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1591_CR44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1369-1600.2008.00106.x","volume":"13","author":"FM Leweke","year":"2008","unstructured":"Leweke FM, Koethe D (2008) Cannabis and psychiatric disorders: it is not only addiction. Addict Biol 13:264\u2013275","journal-title":"Addict Biol"},{"key":"1591_CR45","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","volume":"10","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D (1999a) Elevated endogenous cannabinoids in schizophrenia. NeuroReport 10:1665\u20131669","journal-title":"NeuroReport"},{"key":"1591_CR46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130050884","volume":"142","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, Schneider U, Thies M, M\u00fcnte TF, Emrich HM (1999b) Effects of synthetic \u03949-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. Psychopharmacology 142:230\u2013235","journal-title":"Psychopharmacology"},{"key":"1591_CR47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0091-3057(00)00201-X","volume":"66","author":"FM Leweke","year":"2000","unstructured":"Leweke FM, Schneider U, Radwan M, Schmidt E, Emrich HM (2000) Different effects of nabilone and cannabidiol on binocular depth inversion in man. Pharmacol Biochem Behav 66:175\u2013181","journal-title":"Pharmacol Biochem Behav"},{"key":"1591_CR48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2007.04.025","volume":"94","author":"FM Leweke","year":"2007","unstructured":"Leweke FM, Giuffrida A, Koethe D, Schreiber D, Nolden BM, Kranaster L, Neatby MA, Schneider M, Gerth CW, Hellmich M, Klosterkotter J, Piomelli D (2007) Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophr Res 94:29\u201336","journal-title":"Schizophr Res"},{"key":"1591_CR49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2006.01.008","volume":"29","author":"R Maldonado","year":"2006","unstructured":"Maldonado R, Valverde O, Berrendero F (2006) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 29:225\u2013232","journal-title":"Trends Neurosci"},{"key":"1591_CR50","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0447.1989.tb08579.x","volume":"79","author":"RJ Mathew","year":"1989","unstructured":"Mathew RJ, Wilson WH, Tant SR (1989) Acute changes in cerebral blood flow associated with marijuana smoking. Acta Psychiatr Scand 79:118\u2013128","journal-title":"Acta Psychiatr Scand"},{"key":"1591_CR51","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/jcbfm.1992.106","volume":"12","author":"RJ Mathew","year":"1992","unstructured":"Mathew RJ, Wilson WH, Humphreys DF, Lowe JV, Wiethe KE (1992) Regional cerebral blood flow after marijuana smoking. J Cereb Blood Flow Metab 12:750\u2013758","journal-title":"J Cereb Blood Flow Metab"},{"key":"1591_CR52","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0024-3205(97)00195-1","volume":"60","author":"RJ Mathew","year":"1997","unstructured":"Mathew RJ, Wilson WH, Coleman RE, Turkington TG, DeGrado TR (1997) Marijuana intoxication and brain activation in marijuana smokers. Life Sci 60:2075\u20132089","journal-title":"Life Sci"},{"key":"1591_CR53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0447.1999.tb10916.x","volume":"100","author":"RJ Mathew","year":"1999","unstructured":"Mathew RJ, Wilson WH, Chiu NY, Turkington TG, Degrado TR, Coleman RE (1999) Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. Acta Psychiatr Scand 100:67\u201375","journal-title":"Acta Psychiatr Scand"},{"key":"1591_CR54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(02)00069-0","volume":"116","author":"RJ Mathew","year":"2002","unstructured":"Mathew RJ, Wilson WH, Turkington TG, Hawk TC, Coleman RE, DeGrado TR, Provenzale J (2002) Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography. Psychiatry Research: Neuroimaging 116:173\u2013185","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"1591_CR55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561\u2013564","journal-title":"Nature"},{"key":"1591_CR56","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/sj.npp.1300176","volume":"28","author":"J McDonald","year":"2003","unstructured":"McDonald J, Schleifer L, Richards JB, de Wit H (2003) Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28:1356\u20131365","journal-title":"Neuropsychopharmacology"},{"key":"1591_CR57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"TH Moore","year":"2007","unstructured":"Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370:319\u2013328","journal-title":"Lancet"},{"key":"1591_CR58","unstructured":"Moreau de Tours J-J (1845) Du hachisch et de l'ali\u00e9nation mentale, \u00c9tudes psychologiques. Fortin et Masson, Fortin et Masson"},{"key":"1591_CR59","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1192\/bjp.bp.107.046649","volume":"192","author":"CJ Morgan","year":"2008","unstructured":"Morgan CJ, Curran HV (2008) Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. Br J Psychiatry 192:306\u2013307","journal-title":"Br J Psychiatry"},{"key":"1591_CR60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61\u201365","journal-title":"Nature"},{"key":"1591_CR61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/clpt.1980.181","volume":"28","author":"A Ohlsson","year":"1980","unstructured":"Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK (1980) Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28:409\u2013416","journal-title":"Clin Pharmacol Ther"},{"key":"1591_CR62","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1097\/00001756-200011270-00047","volume":"11","author":"DS O'Leary","year":"2000","unstructured":"O'Leary DS, Block RI, Flaum M, Schultz SK, Boles Ponto LL, Watkins GL, Hurtig RR, Andreasen NC, Hichwa RD (2000) Acute marijuana effects on rCBF and cognition: a PET study. NeuroReport 11:3835\u20133841","journal-title":"NeuroReport"},{"key":"1591_CR63","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0893-133X(01)00425-0","volume":"26","author":"DS O'Leary","year":"2002","unstructured":"O'Leary DS, Block RI, Koeppel JA, Flaum M, Schultz SK, Andreasen NC, Ponto LB, Watkins GL, Hurtig RR, Hichwa RD (2002) Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 26:802\u2013816","journal-title":"Neuropsychopharmacology"},{"key":"1591_CR64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389\u2013462","journal-title":"Pharmacol Rev"},{"key":"1591_CR65","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/BF01930433","volume":"29","author":"M Perez-Reyes","year":"1973","unstructured":"Perez-Reyes M, Timmons MC, Lipton MA, Christensen HD, Davis KH, Wall ME (1973) A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man. Experientia 29:1009\u20131010","journal-title":"Experientia"},{"key":"1591_CR66","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev, Neurosci 4:873\u2013884","journal-title":"Nat Rev, Neurosci"},{"key":"1591_CR67","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0165-6147(00)01482-6","volume":"21","author":"D Piomelli","year":"2000","unstructured":"Piomelli D, Giuffrida A, Calignano A, Rodriguez de Fonseca F (2000) The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 21:218\u2013224","journal-title":"Trends Pharmacol Sci"},{"key":"1591_CR68","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","volume":"188","author":"M Ranganathan","year":"2006","unstructured":"Ranganathan M, D'Souza DC (2006) The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl) 188:425\u2013444","journal-title":"Psychopharmacology (Berl)"},{"key":"1591_CR69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2466\/pms.1977.44.1.3","volume":"44","author":"CF Schaefer","year":"1977","unstructured":"Schaefer CF, Gunn CG, Dubowski KM (1977) Dose-related heart-rate, perceptual, and decisional changes in man following marihuana smoking. Percept Mot Skills 44:3\u201316","journal-title":"Percept Mot Skills"},{"key":"1591_CR70","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ab.2006.11.027","volume":"361","author":"D Schreiber","year":"2007","unstructured":"Schreiber D, Harlfinger S, Nolden BM, Gerth CW, Jaehde U, Schomig E, Klosterkotter J, Giuffrida A, Astarita G, Piomelli D, Markus Leweke F (2007) Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry. Anal Biochem 361:162\u2013168","journal-title":"Anal Biochem"},{"key":"1591_CR71","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511526824","volume-title":"Cannabis and cognitive functioning","author":"N Solowij","year":"1998","unstructured":"Solowij N (1998) Cannabis and cognitive functioning. Cambridge University Press, Cambridge"},{"key":"1591_CR72","first-page":"30","volume":"32","author":"N Solowij","year":"2007","unstructured":"Solowij N, Michie PT (2007) Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci 32:30\u201352","journal-title":"J Psychiatry Neurosci"},{"key":"1591_CR73","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1001\/jama.287.9.1123","volume":"287","author":"N Solowij","year":"2002","unstructured":"Solowij N, Stephens R, Roffman RA, Babor T (2002a) Does marijuana use cause long-term cognitive deficits? JAMA 287:2653\u20132654 author reply 2654","journal-title":"JAMA"},{"key":"1591_CR74","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jama.287.9.1123","volume":"287","author":"N Solowij","year":"2002","unstructured":"Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J (2002b) Cognitive functioning of long-term heavy cannabis users seeking treatment. J Am Med Assoc 287:1123\u20131131","journal-title":"J Am Med Assoc"},{"key":"1591_CR75","doi-asserted-by":"crossref","first-page":"7407","DOI":"10.1523\/JNEUROSCI.23-19-07407.2003","volume":"23","author":"KM Spencer","year":"2003","unstructured":"Spencer KM, Nestor PG, Niznikiewicz MA, Salisbury DF, Shenton ME, McCarley RW (2003) Abnormal neural synchrony in schizophrenia. J Neurosci 23:7407\u20137411","journal-title":"J Neurosci"},{"key":"1591_CR76","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/schbul\/sbn062","volume":"34","author":"PJ Uhlhaas","year":"2008","unstructured":"Uhlhaas PJ, Haenschel C, Nikolic D, Singer W (2008) The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr Bull 34:927\u2013943","journal-title":"Schizophr Bull"},{"key":"1591_CR77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0925-4927(91)90030-T","volume":"40","author":"ND Volkow","year":"1991","unstructured":"Volkow ND, Gillespie H, Mullani N, Tancredi L, Grant C, Ivanovic M, Hollister L (1991) Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose. Psychiatry Res 40:69\u201378","journal-title":"Psychiatry Res"},{"key":"1591_CR78","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-002-1033-2","volume":"161","author":"SR Wachtel","year":"2002","unstructured":"Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H (2002) Comparison of the subjective effects of delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology 161:331\u2013339","journal-title":"Psychopharmacology"},{"key":"1591_CR79","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/clpt.1983.179","volume":"34","author":"ME Wall","year":"1983","unstructured":"Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M (1983) Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther 34:352\u2013363","journal-title":"Clin Pharmacol Ther"},{"key":"1591_CR80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-007-0940-7","volume":"196","author":"A Weinstein","year":"2008","unstructured":"Weinstein A, Brickner O, Lerman H, Greemland M, Bloch M, Lester H, Chisin R, Mechoulam R, Bar-Hamburger R, Freedman N, Even-Sapir E (2008) Brain imaging study of the acute effects of delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana. Psychopharmacology (Berl) 196:119\u2013131","journal-title":"Psychopharmacology (Berl)"},{"key":"1591_CR81","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","volume":"296","author":"RI Wilson","year":"2002","unstructured":"Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678\u2013682","journal-title":"Science"},{"key":"1591_CR82","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","volume":"76","author":"AW Zuardi","year":"1982","unstructured":"Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG (1982) Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology 76:245\u2013250","journal-title":"Psychopharmacology"},{"key":"1591_CR83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2125.2008.03329.x","volume":"67","author":"L Zuurman","year":"2009","unstructured":"Zuurman L, Ippel AE, Moin E, van Gerven JM (2009) Biomarkers for the effects of cannabis and THC in healthy volunteers. Br J Clin Pharmacol 67:5\u201321","journal-title":"Br J Clin Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1591-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-009-1591-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-009-1591-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T03:50:16Z","timestamp":1739159416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-009-1591-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,16]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["1591"],"URL":"https:\/\/doi.org\/10.1007\/s00213-009-1591-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,16]]}}}